Search Thermo Fisher Scientific
Search Thermo Fisher Scientific
Figure 2 - Dose response to VIP of VPAC1 CHO-K1 non-division-arrested and division-arrested cells. VPAC1 CHO-K1 cells (10,000 cells/well) were plated the day before the assay in a 384-well format in division-arrested and non-division-arrested formats. The day of the assay, cells were stimulated with VIP over the indicated concentration range in the presence of 0.5% DMSO for 3 hr. Cells were then loades with LiveBLAzer™-FRET B/G Substrate (2 μM final concentration of CCF4-AM + 1 mM Solution D) for 2 hr. Fluorescence emission values at 460 nm and 530 were obtained using a standard fluorescence plate reader, and the response ratios plotted against the indicated concentrations of VIP (n=6 for each data point).
Figure 3 - Improved assay consistency with division-arrested cells. Three sets of division-arrested (DA) and growing (GR) cells were plated at the same time but entered the assay at three different time points. Better CV and Z' -factor values were observed with division-arrested cells (CV 7.5%, Z'-factor 0.76) than with growing cells (CV 20.1%, Z'-factor 0.38).
GeneBLAzer® GPCR DA cells are stable cell lines derived from our fully validated GeneBLAzer® dividing cells that have been treated with a low dose of mitomycin C. This proprietary treatment causes no apparent toxicity or change in cellular signal transduction. GPCR DA cells are functionally validated using the GeneBLAzer® beta-lactamase readout to determine Z’-factor and EC50 concentrations using a primary agonist (data available upon request). Many cell lines have also been tested using the calcium indicator, fluo-4 NW.
View our complete list of GeneBLAzer® GPCR Division arrested and dividing cell based assays.
Invitrogen acquired Division Arrest technology through our acquisition of Sentigen Holding Corp. As part of the Sentigen transaction, Invitrogen acquired the patent family which includes U.S. Patent No. 7,045,281 and Australian Patent No. 2003270073. Patent applications are currently pending in this family in the United States and a number of other countries.
Screening and Profiling
For Research Use Only. Not for use in diagnostic procedures.